buserelin has been researched along with Growth Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anzo, M; Hasegawa, T; Ishii, T; Matsuo, N; Sasaki, G; Sato, S; Tamai, S | 1 |
| Bourguignon, JP; Craen, M; Delire, M; Du Caju, M; Heinrichs, C; Lambrechts, L; Malvaux, P; Van Vliet, G; Vanderschueren-Lodeweyckx, M; Vandeweghe, M | 1 |
| Brook, CG; Stanhope, R | 1 |
3 other study(ies) available for buserelin and Growth Disorders
| Article | Year |
|---|---|
Treatment with a gonadotropin-releasing-hormone analog and attainment of full height potential in a male monozygotic twin with gonadotropin-releasing hormone-dependent precocious puberty.
Topics: Administration, Inhalation; Administration, Oral; Body Height; Buserelin; Child, Preschool; Cyproterone Acetate; Drug Therapy, Combination; Follow-Up Studies; Gonadotropin-Releasing Hormone; Growth Disorders; Hamartoma; Humans; Hypothalamic Diseases; Magnetic Resonance Imaging; Male; Progesterone Congeners; Puberty, Precocious; Treatment Outcome; Twins, Monozygotic | 1999 |
Evaluation and significance of the degree of pituitary-gonadal inhibition during intranasal administration of buserelin.
Topics: Administration, Intranasal; Adolescent; Bone Development; Breast; Buserelin; Child; Child, Preschool; Dose-Response Relationship, Drug; Estradiol; Female; Follicle Stimulating Hormone; Gonads; Growth Disorders; Humans; Luteinizing Hormone; Male; Pituitary Gland; Puberty, Precocious | 1987 |
The effect of gonadotrophin releasing hormone analogue on height prognosis in growth hormone deficiency and normal puberty.
Topics: Administration, Intranasal; Adolescent; Body Height; Buserelin; Female; Growth; Growth Disorders; Growth Hormone; Humans; Male; Prognosis; Puberty; Sexual Maturation | 1988 |